"Designing Growth Strategies is in our DNA"
Point-of-care testing devices can be defined as a rapid, definite medical diagnostic testing devices of bodily fluids at the bedside. Control of anticoagulation therapy has been plagued with relatively high indigence of adverse reactions, resulting in hemorrhage or thrombosis. This adverse reaction is due to the complexity of anticoagulation or due to the drug’s adverse reaction, which leads to various blood disorders. Therefore, several tests are performed to determine the factors involved in blood clotting to treat coagulating disorder factors.
Point-of-care coagulation (POC) testing devices are increasingly used over the conventional coagulation testing devices because for their rapid and accurate testing of hemostatic function and for the better treatment for patients with coagulopathies. Presently, medical device companies are investing more in research and development of the novel point-of-care coagulation (POC) testing devices which provide accurate and short time results.
To get information on various segments, share your queries with us
The increasing prevalence of bleeding disorders, increasing technological advancements in point-of-care coagulation (POC) testing devices, clinical advantages associated with point-of-care coagulation (POC) testing devices and rising demand for preventive medical care are some of the factors driving the growth of the point-of-care coagulation (POC) testing devices market. Increasing surgical procedures worldwide and growing usage of coagulants are some of the elements driving the market growth.
According to the National Hemophilia Foundation (NHF), Hemophilia A occurs in 1 in 5,000 live births and that the Hemophilia A is about four times common as Hemophilia B. The increasing prevalence of hemophilia subsequently will increase the demand for point-of-care coagulation (POC) testing devices.These trends combined with the other factors are expected to positively drive the market growth.
The factors limiting the growth of the global point-of-care coagulation (POC) testing devices market are the absence of tests for the functioning of the entire hemostatic system in a single device, and the higher cost of point-of-care coagulation (POC) testing devices as compared to conventional coagulation testing devices.
The major companies covered in the global point-of-care coagulation (POC) testing devices market are F. Hoffmann-La Roche Ltd, Accriva Diagnostics, Helena Laboratories, Werfen, Medtronic, Siemens Healthcare GmbH, Danaher, Abbott and Sysmex Corporation.
· Prothrombin Time/International Normalized Ratio (PT-INR) Testing devices
· Bleeding Time Testing devices
· Fibrinogen Level Testing devices
By End User
· North America (USA and Canada)
· Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
· Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
· Latin America (Brazil, Mexico and Rest of Latin America)
· Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)
As per the current point-of-care coagulation (POC) testing devices market trends, Prothrombin Time/International Normalized Ratio (PT-INR) testing devices segment among the type is to register a higher market share in the global point-of-care coagulation (POC) testing devices market owing to increased number surgeries globally. PT-INR test is useful in diagnosing bleeding disorders in patients.
The global point-of-care coagulation (POC) testing devices market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the point-of-care coagulation (POC) testing devices market in 2018. Europe and the Asia Pacific are anticipated to grow at a significant CAGR during the forecast period, due to a number of factors such as the increasing prevalence of bleeding disorders, large number of surgical procedures, established healthcare system, high healthcare expenditure, increased access to advanced point-of-care coagulation (POC) testing devices due to advancements in research & development and rising demand for preventive medical care. Latin America and the Middle East and Africa are expected to grow at relatively lower CAGR during the forecast period of 2019-2026.
“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”- One of the Leading Food Companies in Germany
“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”- Intuitive Surgical
“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”- Major Food Company in Japan
“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”- Ziering Medical
“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”- Major Manufacturer of Precision Machine Parts in India
“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”- Hewlett-Packard
“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”- Global Management Consulting Firm